(For treatment side effects and complications only)
Cabozantinib Protocol V1.2
Larotrectinib NTRK Gene Fusion-positive Solid Tumours Protocol V1.0
Lenvatinib (LENVIMA®) Compassionate Use for Single Patient Metastatic Thyroid Cancer (Off-Label Use) Protocol V1.0
Lenvatinib (LENVIMA®) Differentiated Thyroid Cancer Protocol V1.2
Selpercatinib Ret Fusion-Positive Carcinoma V1.0
Entrectinib - NTRK Gene Fusion-positive Solid Tumours ROS1-positive NSCLC Protocol V1.1